State OR
Clinical Trials in Oregon
Recruiting clinical trials with at least one study location in Oregon. Data updated daily from ClinicalTrials.gov.
Top Conditions in Oregon
Malignant Solid Neoplasm (5)Advanced Solid Tumor (5)Prostate Cancer (4)Acute Myeloid Leukemia (4)Parkinson Disease (4)Myeloproliferative Neoplasm (3)Hematopoietic and Lymphatic System Neoplasm (3)Acute Lymphoblastic Leukemia (3)Atopic Dermatitis (3)Breast Cancer (3)Acute Respiratory Distress Syndrome (3)NSCLC (Non-small Cell Lung Cancer) (3)
NCT06999603 Phase 2
Recruiting
Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respira...
Condition
Viral Pneumonia
Enrollment
550 pts
Location
United States, Belgium, France
Sponsor
Synairgen Research Ltd.
NCT04743141 Phase 3
Recruiting
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatme...
Condition
Acute Treatment of Migraine
Enrollment
600 pts
Location
United States, Poland, Spain
Sponsor
Pfizer
NCT07323654 Phase 2
Recruiting
A Study of KT-621 Administered Orally to Adult Participants With Moderate to Sev...
Condition
Eosinophilic Asthma
Enrollment
264 pts
Location
United States
Sponsor
Kymera Therapeutics, Inc.
NCT06072482 Phase 4
Recruiting
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Condition
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Enrollment
300 pts
Location
United States, Czechia, Hungary
Sponsor
Amgen
NCT04864054 Phase 1, Phase 2
Recruiting
T-Cell Therapy (ECT204) in Adults With Advanced HCC
Condition
Hepatocellular Carcinoma
Enrollment
20 pts
Location
United States, Taiwan
Sponsor
Eureka Therapeutics Inc.
NCT04870944 Phase 1, Phase 2
Recruiting
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS ...
Condition
Diffuse Midline Glioma, H3 K27-Altered
Enrollment
63 pts
Location
United States, Australia
Sponsor
Children's Oncology Group
NCT06410209 Phase 2
Recruiting
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervent...
Condition
Hematopoietic and Lymphatic System Neoplasm
Enrollment
190 pts
Location
United States, Puerto Rico
Sponsor
Children's Oncology Group
NCT06813911 Phase 3
Recruiting
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Partic...
Condition
Atherosclerotic Cardiovascular Disease (ASCVD)
Enrollment
340 pts
Location
United States, China, France
Sponsor
Novartis Pharmaceuticals
NCT05462704 Phase 3
Recruiting
Intravenous Versus Oral Iron for Treating Iron-Deficiency Anemia in Pregnancy
Condition
Iron Deficiency Anemia
Enrollment
300 pts
Location
United States
Sponsor
Women and Infants Hospital of
NCT04097145 N/A
Recruiting
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
Condition
Tricuspid Regurgitation
Enrollment
870 pts
Location
United States, Canada
Sponsor
Edwards Lifesciences
NCT01243931 N/A
Recruiting
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
Condition
Corneal Opacity
Enrollment
80 pts
Location
United States
Sponsor
Oregon Health and Science Univ
NCT07037901 Phase 2
Recruiting
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants Wit...
Condition
Atopic Dermatitis
Enrollment
220 pts
Location
United States, Canada
Sponsor
Inmagene LLC
NCT07225946 Phase 3
Recruiting
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metas...
Condition
Prostatic Neoplasms, Castration-Resistant
Enrollment
800 pts
Location
United States, Australia, Brazil
Sponsor
Janssen Research & Development
NCT05797831 Phase 2, Phase 3
Recruiting
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endo...
Condition
Endometrial Cancer
Enrollment
268 pts
Location
United States, Austria, Canada
Sponsor
Kartos Therapeutics, Inc.
NCT07216872 N/A
Recruiting
Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation...
Condition
Alcohol Use Disorder
Enrollment
186 pts
Location
United States, Israel
Sponsor
Brainsway
NCT06562777 N/A
Recruiting
Observational Study of Sex Differences in Symptoms During Immune Checkpoint Inhi...
Condition
Hematopoietic and Lymphatic System Neoplasm
Enrollment
100 pts
Location
United States
Sponsor
OHSU Knight Cancer Institute
NCT06972459 Phase 3
Recruiting
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight a...
Condition
Obesity
Enrollment
600 pts
Location
United States, Argentina, China
Sponsor
Eli Lilly and Company
NCT03649880 Phase 2
Recruiting
Feasibility of FMISO in Brain Tumors
Condition
Malignant Brain Neoplasm
Enrollment
50 pts
Location
United States
Sponsor
OHSU Knight Cancer Institute
NCT05546580 Phase 1
Recruiting
Study of Iadademstat and Gilteritinib in Patients With R/R AML With FMS-like Tyr...
Condition
Acute Myeloid Leukemia, in Relapse
Enrollment
50 pts
Location
United States
Sponsor
Oryzon Genomics S.A.
NCT06925737 Phase 3
Recruiting
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Pros...
Condition
Prostate Cancer
Enrollment
1,440 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT06402331 Phase 2
Recruiting
FPI-2265 (225Ac-PSMA-I&T) for Patients With PSMA-Positive Metastatic Castration-...
Condition
Metastatic Castration-resistant Prostate Cancer
Enrollment
100 pts
Location
United States
Sponsor
Fusion Pharmaceuticals Inc.
NCT06941272 Phase 1, Phase 2
Recruiting
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refr...
Condition
Malignant Neoplasm
Enrollment
50 pts
Location
United States, Australia, Belgium
Sponsor
Merck Sharp & Dohme LLC
NCT07226895 Phase 1, Phase 2
Recruiting
A Study Exploring Changes in a Variety of Biomarkers Following Dosing With MT198...
Condition
Clinical High Risk for Psychosis (CHR)
Enrollment
150 pts
Location
United States
Sponsor
Monument Therapeutics Limited
NCT05743439 N/A
Recruiting
Early Augmentative and Alternative Communication (AAC) Intervention Delivered Vi...
Condition
Intellectual Disability
Enrollment
50 pts
Location
United States
Sponsor
Oregon Health and Science Univ
NCT07055854 Phase 1
Recruiting
Virtual Mindful After Cancer (MAC) Intervention to Promote Sexual Health for Bre...
Condition
Gynecologic Cancers
Enrollment
60 pts
Location
United States
Sponsor
Oregon State University